The Epigenetics of Chronic Kidney Disease

January 15, 2019 Adam Alonzi

Chronic kidney disease (CKD) affects 20 million people in the United States and an estimated 8 to 16 percent of the world’s population. It is known that anomalous DNA methylation, aberrant histone alterations, and changes to microRNA expression all contribute to its pathogenesis. These epigenetic factors are crucial to the development and proper functioning of the kidneys. The manner and extent to which these factors modulate inflammation, fibrosis, and the transition of mesenchymal to epithelial cells is still being elucidated. The [more…]

HDAC Inhibitors Reduce Kidney Damage Caused by Cancer Therapy

December 29, 2015 Bailey Kirkpatrick

The chemotherapy drug cisplatin has been successful in combating aggressive cancers, including neck and head, lung, and ovarian cancers, for nearly 40 years. However, many patients suffer from kidney damage as a result of the drug and there is currently no therapy available for treating or preventing cisplatin nephrotoxicity. Researchers have found that histone deacetylase (HDAC) inhibitors can improve the kidneys in the presence of the cancer drug by eliminating 80 to 90 percent of kidney toxicity. They published their [more…]


If you like reading our articles…

Join our e-newsletter! Stay up-to-date with our weekly posts on epigenetics and health, nutrition, exercise, and more.